Abstract

A desire for both transparency in research and widespread access to the results of research has led to activism in support of open access publishing. Open access publishing, particularly publishing industry-sponsored research, can be complex. The overarching benefits of, and challenges to, open access are described, illustrated with the initiatives related to Medical Publishing Insights and Practices to help promote a better understanding of open access and its importance in ensuring transparency in industry-sponsored research.

Highlights

  • The growing advocacy for access to results of clinical trials has generated interest and debate around open access (OA) publication of these results

  • If authors – or those who funded the research being published – wish to make their article OA, or freely available to all, they can pay for gold standard of OA (Gold OA) or wait for the article to be made available after an embargo period; alternatively, the authors can follow the traditional publishing route, in which articles are available only to those who subscribe to the journal in which the article is published or to those who pay for the article in question

  • An analysis of OA policies of 21 medical journals with high impact factors (>15) indicated that most journals did not offer commercial organizations the option to use a CC BY Creative Commons licence, which allows free reuse and sharing of the work.[6]

Read more

Summary

Introduction

The growing advocacy for access to results of clinical trials has generated interest and debate around open access (OA) publication of these results.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call